Catalyst Wire Dossier Catalyst Wire Dossier

Riboflavin/UVA corneal cross-linking

riboflavin with ultraviolet-A light cross-linking
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Riboflavin/UVA corneal cross-linking, covering 2010-04-19 to 2010-04-19. Get the full timeline:

Most recent: Clinical Trial Update: The Effects of Riboflavin/ Ultraviolet-A Corneal Cross-linking on the Signs and Symptoms of Bullous Keratopathy [NA]

See pricing